MRM Medirom Healthcare Technologies

MEDIROM Healthcare Technologies Inc., Announces the Timing of its Release of 2021 Interim Earnings

MEDIROM Healthcare Technologies Inc., Announces the Timing of its Release of 2021 Interim Earnings

NEW YORK, Aug. 19, 2021 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a Japanese based holistic healthcare Company (the “Company”), today announced its intention to release interim financial results for the six months ended June 30, 2021 (the “2021 Interim Results”) at or around the end of October 2021.

As a foreign private issuer, the Company is not required under U.S. federal securities laws to file quarterly reports (including quarterly financial information) on Form 10-Q and has no similar obligation under applicable Japanese law. Accordingly, in order to provide insight into the business fundamentals and progress of the Company, the Company has been disclosing monthly Key Performance Indicators, or KPIs, since March 2021 on the investor relations page of its website at , copies of which have been filed with the SEC on Form 6-K.

The Company is planning to release the 2021 Interim Results at the end of October 2021, and intends to continue to disclose monthly KPIs to show its business progress.

MEDIROM operates 314 (as of July 31, 2021) relaxation salons across Japan, Re.Ra.Ku™, being its leading brand, and provides healthcare services. In 2015, MEDIROM entered the health tech business, and launched new healthcare programs using on-demand training app called "Lav™", which is developed by the company. MEDIROM also entered the device business in 2020 and is developing a smart tracker "MOTHER Tracker™". MEDIROM plans to expand the scope of its business to include data analysis utilizing the data it has collected since formation of the company.



URL

Contacts

Investor Relations Team



EN
19/08/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Medirom Healthcare Technologies

 PRESS RELEASE

Series A Round Valuation: ¥9 Billion: MEDIROM MOTHER Labs Inc. Decides...

Series A Round Valuation: ¥9 Billion: MEDIROM MOTHER Labs Inc. Decides to Make an Investment from Internal Investors TOKYO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- MEDIROM MOTHER Labs Inc. (Headquarters: Minato-ku, Tokyo; President and CEO: Yoshio Uekusa; hereinafter “MOTHER Labs”), a subsidiary of MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM), today announced that it has approved a private placement of new shares to two officers, Yoshio Uekusa, President and CEO, and Ryo Saito, Director, as part of its Series A financing round, at a valuation of JPY9 billion. Funding is scheduled to occur...

 PRESS RELEASE

Medirom Decides to Double Installation of Authentication Device “Orb” ...

Medirom Decides to Double Installation of Authentication Device “Orb” to 200 Stores, in Collaboration with “World” Co-founded by Sam Altman and Alex Blania TOKYO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; CEO: Kouji Eguchi; NASDAQ: MRM), a diversified healthcare company, has joined “World,” a “proof of human” protocol co-founded by Sam Altman and Tools for Humanity’s CEO, Alex Blania. MEDIROM plans to complete the deployment of the World ID proof of human authentication device Orb across 100 of its Re.Ra.Ku relaxation studio...

 PRESS RELEASE

Japan Ground Self-Defense Force Adopts MEDIROM MOTHER Labs’ REMONY for...

Japan Ground Self-Defense Force Adopts MEDIROM MOTHER Labs’ REMONY for Advanced Health Monitoring and Heatstroke Safety TOKYO, Sept. 18, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) today announced that its subsidiary, MEDIROM MOTHER Labs Inc. (“MOTHER Labs”), has begun providing its remote health monitoring system “REMONY,” powered by the recharge-free smart tracker MOTHER Bracelet®, to the Japan Ground Self-Defense Force (JGSDF).■Background of the Deployment In recent years, the importance of health management and heatstroke prevention f...

 PRESS RELEASE

Medirom’s “REMONY” Certified by MLIT as a Fatigue-Driving Prevention D...

Medirom’s “REMONY” Certified by MLIT as a Fatigue-Driving Prevention Device TOKYO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”, “we” or “us”) announces that its “REMONY for Driver” remote health management system, developed by its subsidiary MEDIROM MOTHER Labs Inc. (“MOTHER Labs”), has been selected by Japan’s Ministry of Land, Infrastructure, Transport and Tourism (“MLIT”) under its Accident Prevention Support and Promotion Program as a certified device for preventing fatigue-related driving. ■ About REMONY for Driver“REMONY for Dri...

 PRESS RELEASE

MEDIROM launches cryptocurrency strategy with next-generation proof of...

MEDIROM launches cryptocurrency strategy with next-generation proof of human technology, "World" Acquires ETH as part of financial strategy TOKYO, Aug. 22, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; CEO: Kouji Eguchi; NASDAQ: MRM) (the “Company”, “we” or “us”), which operates a diversified healthcare business, announced its participation in “World,” a “proof of human” protocol co-founded by Sam Altman and Alex Blania. The purpose of this project is to build a new digital infrastructure that will enable "proof of humanness" in the ag...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch